Translational Research Business

Translational Research Business

The Translational Research Business bridges the gap from basic to clinical research, engaging in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities.

The role of clinical CROs in pharmaceutical development

In addition to licensing out new drugs and platform technologies that have advanced to the development stage to partner pharmaceutical companies, the SNBL Group maximizes the use of its facilities, equipment, and extensive expertise based on experience in pharmaceutical research and development to swiftly and meticulously support each partner's pharmaceutical development needs.

Translational Research Business

Please see http://www.snbl-nds.co.jp/, regarding the Translational Research Business.

For more details about our business, please contact us directly.

Contact